Showing results (911-920 of 932) with videos related to
Sort By:
Pageof 94
Nature|May 20, 2005
An inhibitor of Bcl-2 family proteins induces regression of solid tumoursTilman Oltersdorf, Steven W Elmore, Alexander R Shoemaker, et al.Science (New York, N.Y.)|March 30, 2019
Close Cassini flybys of Saturn's ring moons Pan, Daphnis, Atlas, Pandora, and EpimetheusB J Buratti, P C Thomas, E Roussos, et al.Molecular Cancer Therapeutics|March 31, 2021
Expanding the Repertoire for "Large Small Molecules": Prodrug ABBV-167 Efficiently Converts to Venetoclax with Reduced Food Effect in Healthy VolunteersAhmed Hamed Salem, Zhi-Fu Tao, Orlando F Bueno, et al.Nature Protocols|December 13, 2023
Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practiceKris G Samsom, Linda J W Bosch, Luuk J Schipper, et al.Nature|September 28, 2017
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren M Lasko, Clarissa G Jakob, Rohinton P Edalji, et al.Nature|May 18, 2018
Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumoursLoren M Lasko, Clarissa G Jakob, Rohinton P Edalji, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2022
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic TherapyVincent M T de Jong, Yuwei Wang, Natalie D Ter Hoeve, et al.ACS Medicinal Chemistry Letters|October 15, 2014
Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo ActivityZhi-Fu Tao, Lisa Hasvold, Le Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor modelsCherrie K Donawho, Yan Luo, Yanping Luo, et al.Science Advances|October 4, 2024
BCL-XL-targeting antibody-drug conjugates are active in preclinical models and mitigate on-mechanism toxicity of small-molecule inhibitorsAndrew S Judd, Bhupinder Bawa, Wayne R Buck, et al.Pageof 94